Bioject Medical Technologies Inc., (OTCBB: BJCT), a leading developer of
needle-free injection therapy systems, announced today that the Company
will hold its Annual Shareholder Meeting on Thursday, June 9, 2011 at
9:00 a.m. Pacific Daylight Time at its corporate office in Tualatin,
Oregon.
Live audio of the Annual Meeting will be available to investors, members
of the news media and the general public. To access the call, please
dial 1-877-407-8037. A replay will also be available until June 16,
2011. To listen to the replay, please dial 1-877-660-6853, replay
account number 7303, identification number 373862.
Bioject Medical Technologies Inc., based in Portland, Oregon, USA, is an
innovative developer and manufacturer of needle-free injection therapy
systems (NFITS). NFITS provide an empowering technology and work by
forcing medication at high speed through a tiny orifice held against the
skin. This creates a fine stream of high-pressure fluid penetrating the
skin and depositing medication in the tissue beneath. Bioject is focused
on developing mutually beneficial agreements with leading
pharmaceutical, biotechnology, and veterinary companies, as well as
research, global health and government organizations.
For more information about Bioject, visit: www.bioject.com.
